_:n53bc59f88a17478782a6e7c92bfe4841xb0
<http://schema.org/description>
"During a press confernece at the 2013 ASH Annual Meeting, Dr Michael Kalos presents data on an overview of patient response in a clinical research program evaluating treatment of paediatric and adult leukaemia patients with experimental CAR genetically engineered T cells. A series of treatment cohorts were included in the analysis, including paediatric and adult patients with high-risk, treatment-resistant acute lymphocytic leukaemia and adult patients with advanced relapsed and/or treatment-resistant chronic lymphocytic leukaemia.\r\n\r\n\tRead our ASH 2013 conference report for free."
<https://ecancer.org/en/video/2528-long-term-functional-persistence-b-cell-aplasia-and-anti-leukaemia-efficacy-in-refractory-b-cell-malignancies>